DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
  • Stocks
  • /
  • Pharmaceuticals & Biotech
Updated 1d ago
XBRA.F logo

Xebra Brands Ltd.OTCPK:XBRA.F Stock Report

Market Cap US$300.7k
Updated 1d ago
Share Price
n/a
1Y-99.9%
7D0%
1D-99.0%
Portfolio Value
​
View

Xebra Brands Ltd.

OTCPK:XBRA.F Stock Report

Market Cap: US$300.7k

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Xebra Brands (XBRA.F) Stock Overview

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico. More details

XBRA.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Shares are highly illiquid

Has not reported any financial data

Does not have a meaningful market cap ($301K)


XBRA.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW425,311 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
425,311 investors already sharing narratives
US$
Current Price
US$0.000001n/aintrinsic discount
Est. Revenue
$
PastFuture012016201920222025202620282031Revenue US$1.0Earnings US$0.1
Advanced
View all narratives

Xebra Brands Ltd. Competitors

Petros Pharmaceuticals

Symbol: OTCPK:PTPI
Market cap: US$233.0k

Altamira Therapeutics

Symbol: OTCPK:CYTO.F
Market cap: US$505.8k

CBD Life Sciences

Symbol: OTCPK:CBDL
Market cap: US$1.2m

Clearmind Medicine

Symbol: NasdaqCM:CMND
Market cap: US$2.7m

Price History & Performance

Summary of share price highs, lows and changes for Xebra Brands
Historical stock prices
Current Share PriceCA$0.000001
52 Week HighCA$0.05
52 Week LowCA$0.000001
Beta0
1 Month Change-99.00%
3 Month Changen/a
1 Year Change-99.90%
3 Year Change-99.90%
5 Year Changen/a
Change since IPO-99.90%

Recent News & Updates

Recent updates

Shareholder Returns

XBRA.FUS PharmaceuticalsUS Market
7D0%-0.07%-1.1%
1Y-99.9%45.4%11.7%

Return vs Industry: XBRA.F underperformed the US Pharmaceuticals industry which returned 45.4% over the past year.

Return vs Market: XBRA.F underperformed the US Market which returned 11.7% over the past year.

Price Volatility

Is XBRA.F's price volatile compared to industry and market?
XBRA.F volatility
XBRA.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement8.4%
Market Average Movement6.9%
10% most volatile stocks in US Market15.2%
10% least volatile stocks in US Market2.9%

Stable Share Price: XBRA.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine XBRA.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2019n/aRodrigo Gallardoxebrabrands.com

Xebra Brands Ltd. engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers its products under the HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle brands.

Xebra Brands Ltd. Fundamentals Summary

How do Xebra Brands's earnings and revenue compare to its market cap?
XBRA.F fundamental statistics
Market capUS$300.65k
Earnings (TTM)US$0
Revenue (TTM)n/a
n/a
P/E Ratio
n/a
P/S Ratio

Is XBRA.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XBRA.F income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$0
EarningsUS$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did XBRA.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/17 03:38
End of Day Share Price 2026/09/03 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xebra Brands Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide